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iii. Abstract 
 
Surface-Enhanced Raman spectroscopy (SERS) is a technique that is preferred over 
conventional Raman spectroscopy. The main advantage of SERS is that the intensity of the 
Raman signal is enhanced up to 104 to 106 fold thus allowing low concentrations of the 
analyte to be detected. The use of oral fluid for detecting drugs of abuse is increasing in 
popularity as the methods of collecting saliva are not as invasive as other biological fluids 
(blood or urine).  As SERS can detect low limits of substances, the use of this technique 
coupled with the analysis of oral fluid for the detection of drugs is becoming popular. This 
technique could have applications in roadside testing, drug testing and medical care. The 
constant appearance of caffeine present in new psychoactive substances is becoming 
increasingly common. There are a lot of the drugs that are being sold on the market that 
only contain caffeine rather than the stated drug. A market is opening up for the detection 
of drugs in saliva using a rapid portable testing kit. This work focuses on the analysis of 
caffeine as it is a common adulterant that it found in illegal and legal drugs of abuse. A 
reproducible silver colloid with strong surface-enhancement and good shelf life was used to 
optimise a method capable of analysing caffeine. The colloid was produced by the reduction 
of silver nitrate with hydroxylamine phosphate. An optimised SERS method was developed 
that was capable of detecting caffeine in methanolic solutions, however when analysing 
caffeine in saliva there were problems that meant a spectrum could not be obtained. A 
HPLC method was developed for the quantification of caffeine. The HPLC method was 
successfully able to detect and quantify caffeine in saliva using 8 independent participants, 
the participants were asked to go 24 hours without any form of caffeine, and they were 
then required to give a saliva sample before and after the consumption of caffeine. The 
caffeine concentrations ranged between 1.51-1.94 µg/mL. The HPLC results show that 
caffeine was present at levels that should have been detected by the SERS method. Further 
investigation is needed to determine why SERS couldn’t detect caffeine in saliva; this could 
be due to other substances present in saliva.           
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1. Introduction  
 
There are a wide variety of different analytical techniques that are being used to analyse 
drugs of abuse and legal highs. The most common technique used is gas chromatography-
mass spectrometry (GC-MS) as it is sensitive and selective, other techniques that have been 
developed are thin-layer chromatography (TLC), high performance liquid chromatography 
(HPLC) and immunoassays. HPLC is normally a secondary choice however HPLC can be 
applied to water soluble compounds which are increasing rapidly within the toxicological 
field (Nakashima, 2005). 
One method that has been looked at to determine specific drugs within saliva samples is 
surface-enhanced Raman spectroscopy (SERS) (Shende et al., 2005). The main advantage of 
using SERS is that unlike immunoassays it is not subject to interferences that can lead to 
false positives. A further advantage of SERS is that when using sophisticated instruments like 
GC-MS to identify and quantify illicit drugs the analysis is usually time-consuming and 
labour-intensive (Wood et al., 2003). SERS however, only takes a few minutes. The use of 
saliva is also beneficial as again it is non-invasive, samples are easy to collect, drugs are 
represented in concentrations similar to blood plasma (µg/mL) and as saliva is 99.5% water 
the number of steps required to remove any chemical interferences is significantly fewer 
(Farquharson et al., 2005).  
High performance liquid chromatography (HPLC) is becoming an increasingly popular 
chromatographic method used to analyse different drugs of abuse and adulterants 
especially within saliva. The use of oral fluid for the analysis of drugs of abuse is an 
attractive alternative to plasma and urine which are currently the most commonly 
investigated. Collection of saliva is non-invasive and requires no specialist equipment and 
can be supervised, removing sample contamination which is of great importance for 
forensic toxicologists.   
The aim of this research is to be able to identify caffeine within oral fluid by SERS using a 
silver colloid and quantify using a HPLC method. 
2. Literature Review  
 
2.1 Caffeine 
Caffeine is a xanthine alkaloid that is used as a stimulant drug. It has a melting point of 235-
238°C, is moderately soluble in water at room temperature (2g/100 mL) however, very 
soluble in boiling water (66 g / 100 mL). It is weakly basic with a pKa of 0.6. Caffeine is 
classified as an achiral molecule as it does not contain any stereogenic centres (Chen, Gu, 
Shen, Dong, & Kang, 2010). The core of a caffeine molecule contains two fused rings; 
pyridine (6-membered) ring and imidazole (5 membered) ring (Chen et al., 2010) (figure 1). 
The pyridine ring alone contains two amide groups and two tertiary amine function groups. 
The imidazole ring contains one amide group and one tertiary amine, along with an alkene 
functional group (Chen et al., 2010). 
 
It can be found in different foods and plants. It is often consumed in the form of tea, coffee, 
energy drinks etc. In the human body it acts as a central nervous system (CNS) stimulant by 
restoring alertness, preventing drowsiness and helps increase cognitive function (Tabassum 
et al., 2012). It is the world’s most widely consumed psychoactive drug that is legal. Within 
30-40 minutes of consumption caffeine reaches its highest concentration in the blood and 
brain and caffeine has a half-life of 4-6 hours (Tabassum et al., 2012). 
 
Caffeine is commonly found as an adulterant in street drugs such as amphetamine, cocaine, 
heroin, ecstasy and sympathomimetic recreational drugs (NPS) (Davies et al., 2012; 
Vanattou-Saïfoudine et al., 2012). However as there is often limited information regarding 
the contents of these products they could contain other compounds such as caffeine. It is 
plausible that caffeine could serve to promote these reactions when taken in combination 
with illicit psychostimulants. The harmful effects caffeine has when consuming other 
psychostimulants is becoming problematic as many controlled and uncontrolled drugs 
contain some caffeine. Table 1 shows different papers that have been published where 
caffeine was found mixed with other drugs and NPS or caffeine was the main active 
ingredient.  
 
Table 1: List of different drugs and NPS where caffeine was found  
References  Ingredient stated Main Active Ingredient  Caffeine present  
 
Baron et al (2011) 
MDAI Caffeine  Yes  
5-IAI 5-IAI Yes  
NRG-3 6-APB Yes 
 
Davies et al (2012) 
Legal High  Caffeine  Yes 
Legal High  Caffeine  Yes 
Legal High Caffeine  Yes 
Vanattou-saïfoudine  
et al (2012) 
MDMA MDMA Yes 
Amphetamine  d-amphetamine  Yes 
 
O’Bryne et al (2013) 
Methedrone  Methedrone  Yes 
Fluoromethcathinone Fluoromethcathinone Yes 
 
 
 
Brant et al (2010) 
NRG-1 Caffeine, mephedrone 
traces 
Yes 
DMC Caffeine, lidocaine  Yes 
NRG-1 Caffeine  Yes 
NRG-2 Benzocaine  Yes 
NRG-1 Caffeine  Yes 
 
Table 1 demonstrates that a lot of drugs that are being sold may only contain caffeine 
particularly in the sale of NPS. If people are taking a drug that they believe to have a 
psychoactive substance in but only contains caffeine and do not feel any effect from the 
drug then they could possibly take more which could result in a caffeine overdose.  
 
Over 300 people consume caffeine on a daily basis (Vanattou-Saïfoudine et al., 2012). The 
daily intake normally ranges from 50 mg - 150 mg (Vanattou-Saïfoudine et al., 2012). 
Caffeine overdoses have been associated with oral consumption of between 3 and 20 g 
(Vanattou-Saïfoudine et al., 2012). It has been reported that caffeine has the potential to 
influence the toxicity of other stimulants. Derlet et al (1992) administered caffeine and 
amphetamine or cocaine to rats and it was found that it resulted in seizures and mortality 
when compared to the administration of amphetamine or cocaine alone. It has also been 
demonstrated more recently when caffeine and MDMA were administered to rats that it 
caused seizures, tachycardia and hyperthermia (McNamara et al., 2007).  
 
There have been a number of reports of the toxicity of caffeine. In 2014, Smith, reported 
that an 18 year old girl on a night out had drunk Jagerbombs (mixture of Jagermeister spirit 
and caffeine-filled energy drinks). Eight hours after she had consumed these drinks she 
collapsed in her bathroom at home. Her family had to perform CPR three times in order to 
keep her alive. Once she was admitted to hospital she was put in a coma for 52 hours to 
protect her brain and heart. The medics informed the family that when the alcohol she had 
drunk had worn off the caffeine in her system took control of her heart beat. To ensure her 
heart beat remained normal a defibrillator was implanted under her skin to shock her heart 
back to a normal rhythm. Doctors have informed people that children and young adults are 
at a potential risk from high amounts of energy drinks as their smaller bodies are not used 
to the effects and it can cause heart palpitations. It has also been reported that a 40 year 
old man died last year from a caffeine overdose after eating a pack of 12 energy mints 
(Smith, 2014).     
 
Inside the body caffeine counteracts adenosine (Fredholm, 2011a). Adenosine acts as an 
inhibitory neurotransmitter that suppresses activity in the CNS, as caffeine readily crosses 
the blood-brain barrier it blocks the adenosine receptors as it is structurally similar and acts 
as a competitive inhibitor preventing drowsiness (Fredholm, 2011a). Caffeine also interacts 
with dopamine which could be the cause of caffeine’s addictive nature (Alpert, 2012).  
 
There are three metabolites of caffeine; paraxanthine, theobromine and theophylline. 
Caffeine is metabolised primarily by demethylation in phase 1 liver detoxification by the 
CYP450 system, specifically 1A2 (Alpert, 2012; Benowitz et al., 1995) which can be seen in 
Figure 1. Over 80% of caffeine administered metabolises to paraxanthine, 16% is converted 
to theobromine and theophylline (Xu et al., 2010). Paraxanthine increases the lipolysis 
process, releasing glycerol and fatty acids into the body as a fuel source for muscles (Alpert, 
2012). Theobromine is predominantly found in chocolate and can also be found in small 
quantities in tea (Fredholm, 2011b). Theobromine increases the amount of oxygen and 
nutrient flow to the brain and muscles by dilating the blood vessels (Alpert, 2012). 
Theophylline acts as a smooth muscle relaxant that increases the heart rate and force of 
contraction and is widely employed in the treatment of bronchial asthma (Alpert, 2012). 
These metabolites are then broken down further and excreted in urine (Alpert, 2012).  
 
Figure 1: metabolism of caffeine in the liver.  
 
   
 
 
 
 
 
 
 
 
 
 
 
Caffeine is commonly used in psychoactive substances as either a replacement for the active 
drug or as a cutting agent (table 1). Being able to detect caffeine in saliva may also result to 
being able to detect different psychoactive substances as well.   
 
2.2 New psychoactive substances  
New psychoactive substances (NPS) are commonly known as ‘legal highs’ and are 
increasingly being used throughout European countries (Davies et al., 2012). The 
Government has openly stated that just because these substances are called ‘legal highs’ it 
does not make them safe to use as they have not been subjected to the stringent testing 
procedure which are required before they are granted a licence (ACMD, 2011). NPS 
normally fall broadly into four categories (ACMD, 2011): 
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They are sold either on the internet or in head shops. Generally, these substances contain 
stimulant drugs that mimic the effects of drugs that have been controlled such as 
amphetamine and ecstasy. Synthetic substances have increased in popularity which are 
causing problems for authorities as they are unable to act quickly enough to monitor and 
legislate the vast array of substances (Ayres et al., 2012) Due to an increase in these 
substances there has been a corresponding increase in published papers reporting on their 
adverse effects (Gibbons, 2012). Their chemical composition, toxicity and their long-term 
effects pose a challenge to public health agencies as little is known about them. Many of 
these substances have already been categorised under the Misuse of Drugs Act for example 
mephedrone and a group of spice compounds that have a specific chemical structure. 
However, despite these controls it is evident that these banned substances are still being 
sold under different names (Ayres et al., 2012). Scientists are unsure of what products 
contain newly synthesised drugs and how many contain controlled substances. In order to 
protect people from the harmfulness of these NPS’s, a temporary class order was 
introduced in 2011 by the Advisory Council on the Misuse of Drugs Act, 1971 (ACMD). This 
enables the ACMD to put a temporary ban on new ‘legal highs’ for 12 months while health 
issues regarding these substances are considered. An example of where this has already 
been put in place is with methoxetamine (MXE) (Ayres et al., 2012). Methoxetamine’s 
chemical structure resembles that of ketamine which is a Class C drug. It has been reported 
that the effects of methoxetamine are similar to ketamine; severe dissociation, paranoid 
thoughts, hallucinations and cardiovascular symptoms. However it has also been reported 
that the effects of MXE are of a longer duration. The ACMD recognises that the effects of 
MXE are commensurate with Class B substances and it should be scheduled under Schedule 
1 of the Misuse of Drugs Regulations (2001) (ACMD, 2012). Since then a new act has been 
brought in, the Psychoactive Substance Act (2016). This Act has been brought in to restrict 
the production, sale or supply of psychoactive substances and is not intended to criminalise 
possession. However it does criminalise supply, so head shops and internet sites are unable 
to supply them anymore. There are three exceptions which are caffeine, alcohol and 
nicotine (Home Office, 2016).  
 
Many of these NPS are being substituted with other adulterants for example caffeine 
(Davies et al., 2012). Davies et al (2012) looked at the risk of caffeine toxicity associated with 
the use of NPS. They looked at six different novel psychoactive substances purchased from 
internet suppliers. They concluded that all six substances contained caffeine; no other active 
compounds were identified in the screening procedure. They found that there was a wide 
variation of caffeine. Four of the substances had high proportions of caffeine at 87, 94, 94 
and 96% equating to more than 870 mg of caffeine in 1 gram of product. This study shows 
that people who do buy NPS are at risk of caffeine toxicity related to the high caffeine 
content. They suggested that a potential reason caffeine was used instead of the intended 
NPS was to mimic the stimulant effects of the said NPS. It could also have been possible that 
the suppliers did this because caffeine is much cheaper.   
 
 
2.3 Drug screening analysis  
Delivering accurate and precise chemical analysis on different legal and illegal drugs of 
abuse is becoming difficult as the work load in forensic labs continues to increase (Stoll et 
al., 2006). This is encouraging the development of analytical techniques that can provide 
high quality quantitative and qualitative analyses. No single technique has an overwhelming 
predominance for screening analysis; the majority of cases require a number of different 
techniques.  
 
Gas chromatography using flame ionisation detection (GC-FID) was used for screening 
purposes (Foerster et al., 1978) however gas chromatography mass spectrometry (GC-MS) 
has replaced the use of GC-FID and is currently considered as the ‘golden-standard’ 
technique for drugs of abuse analysis (Øiestad et al., 2007; Stoll et al., 2006). GC-MS is a 
well-established technique that provides high resolution separation, high selectivity and 
sensitivity (Pragst et al., 2004). However, there are several limitations for using this analysis 
as a screening technique. The mass spectrometer as a detector is expensive and can be 
unavailable to labs with limited resources. Another limitation with the GC-MS is that not all 
analytes can be distinguished. A study done by Elie et al (2012) found that when analysing a 
number of novel psychoactive substances, 5- and 6-APB coelute. A way to combat this 
problem is by using derivatisation, which increases the volatility of analytes and changes 
their mass spectra, which in turn affects the retention time. Derivatisation can be costly, 
time consuming, and susceptible to errors that can affect the quality of the results 
(Leinonen et al., 2002).  
 
Due to limitations cited above liquid chromatography is looked at to resolve some of them. 
High performance liquid chromatography (HPLC) has been used as a complementary 
method to the GC as it separates a wider range of compounds without the need for pre-
treatment for example derivatisation (Concheiro et al., 2005). HPLC requires a detector 
normally a diode-array detector (DAD) which records the absorbance of compounds and 
produces a UV spectrum (Elliott & Hale, 1998). HPLC-DAD is a very important tool in the 
identification of substance. With HPLC some classes of drugs can exhibit similar UV spectra, 
therefore it is desirable to have a second parameter namely the retention time (Elliott & 
Hale, 1998).  
 
2.4 Chromatographic Techniques  
2.4.1 High Performance Liquid Chromatography (HPLC) 
HPLC has commonly been a secondary choice in comparison to GC-MS. However, HPLC can 
be applied to water-soluble compounds making it essential for forensic and toxicological 
fields. The development of these HPLC methods for analysing drug-related substances has 
rapidly increased within the last 10 years (Nakashima, 2005). HPLC works by passing a liquid 
sample through a column containing a solid adsorbent material. Different analytes interact 
differently with the column, thus delaying the flow of the analytes. With weak interaction, 
the analytes elute off the column in a short time, and with strong interaction, the elution 
time is longer.  
 
HPLC uses many different detectors, such as ultraviolet (UV), electrochemical (EC), 
fluorescence (FL), diode array (DAD) or mass spectral (MS) (Nakashima, 2005; Saxon et al., 
1988). HPLC is an alternative technique to GC that is very useful for compounds that are 
polar and thermolabile. This method is rapidly growing in the detection of abused drugs due 
to its simple sample preparation (Tsai et al., 2013). 
  
Table 2: Previous HPLC methods used for the detection of drugs of abuse in biological fluids 
References  Analytes 
Validated  
Column  Mobile Phase  Flow rate 
(mL/min)  
Detection 
wavelength 
Run time 
(min) 
Alvi et al 
(2011) 
Caffeine  C18 Potassium 
Phosphate – 
acetonitrile 
(83:17) 
1.0 274 nm 10 
Tsai et al 
(2013) 
Drugs of 
abuse and 
metabolites 
  
EC-C18 Acetic acid – 
Methanol  
0.4  14 
Perera et al 
(2010) 
Caffeine  
Paraxanthine 
C18 
Ultrasphere 
ODS 
Acetonitrile – 
acetic acid – 
water 
(100:1:899) 
1.5 280 nm 15 
Mumin et al 
(2006) 
Caffeine   Potassium  
dihydrogen 
phosphate – 
acetonitrile - 
methanol 
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Alvi et al (2011) devised a method for the determination of caffeine levels in human plasma 
using the HPLC. They found that caffeine had a retention time of 4.7 minutes and the run 
time took 10 minutes. Two hundred microliters of the internal standard (antipyrine) was 
added to 500 µl of the plasma samples. The samples then underwent vortexing and 
centrifugation at 12000 rpm. The supernatant was collected and injected into the 
chromatographic system. They were able to determine the limit of quantitation using 
caffeine free plasma. It was concluded that the limit of quantitation was 0.05 µg/mL and the 
lowest detection limit was 0.02 µg/mL. Plasma samples from volunteers were analysed 
using this HPLC method, the mean caffeine level for these volunteers was 0.28 µg/mL after 
abstaining from beverages and food containing caffeine for 16 hours. Their plasma was then 
analysed 3 hours after the ingestion of 300 mg of caffeine.    
 
Tsai et al (2013) developed a simple and effective HPLC method that was coupled with 
quadrupole time-of-flight mass spectrometry to screen and confirm abused drugs. This 
method was used to analyse 10 urine samples of patients that were undergoing methadone 
therapy. They were also able to analyse 62 abused drugs and their metabolites. The results 
obtained showed good selectivity, precision and detection sensitivity. 
 
Another study used HPLC for the analysis of caffeine in saliva (Perera et al., 2010). They 
looked at the analysis and stability of caffeine and paraxanthine in saliva and plasma. For 
the development of their study they used concentrations of 1.0 mg/mL for paraxanthine 
and 2.5 mg/mL for caffeine as these represent the Cmax values observed in a single oral dose 
of 100 mg of caffeine. Perera et al (2010) also investigated the stability of these two 
substances in oral fluid. The two different conditions that were investigated were 
refrigerated samples at 4⁰C and room temperature ranging from 9-30⁰C. They concluded 
that paraxanthine and caﬀeine were stable at both temperatures over a 14 day period and 
the concentration did not vary. Two healthy, non-smokers received a caffeine dose of 100 
mg after a 24 hour abstinence and their saliva and blood were collected at different 
intervals over a 24 hour period. They found that caffeine eluted at 10.5 min, paraxanthine at 
5.5 min and the internal standard (benzotriazole) at 14.2 min. The concentration of both 
caffeine and paraxanthine fell within the validated range over the 24 hour period. The Cmax 
value for caffeine in saliva was 1.2 and 1.9 µg/mL for participant 1 and 2 respectively and 
the half-life was 5.9 and 4.9 respectively.  
 
2.5 Raman Spectroscopy 
Raman scattering occurs by a shift in photon frequency which is a result of excitation or 
deactivation of molecular vibrations i.e. the photon may either gain energy causing a shift 
up or lose energy causing a shift down (Das & Agrawal, 2011). Raman spectroscopy is 
becoming increasingly popular as it is possible to acquire spectra quickly, easily and is 
affordable. In many cases Raman spectroscopy has been coupled with different analytical 
techniques such as, HPLC, microchromatography, atomic force microscopy and many more 
(Das & Agrawal, 2011). 
 
Two main features of Raman spectroscopy which make it a useful method for screening 
tablets/powders are, the ability to record spectra with no sample preparation and the short 
analysis time (Bell et al., 2000). The spectra not only can identify the active drugs they can 
also identify excipients, the relative concentration of the drug to excipient and the degree of 
hydration. This gives Raman an edge in comparison to commercial GC-MS where this 
technique can identify and quantify the active compound but doesn’t give any other 
information on tablet composition (Bell et al., 2000). Raman spectra can be acquired rapidly 
suggesting that it would be able to analyse hundreds of samples in just a few hours. In 
contrast, only a small number of individual tablets are analysed with GC-MS due to time 
required for each measurement (Bell et al., 2000).  
 
Though Raman spectroscopy has many advantages over other analytical techniques, it also 
comes with its own limitations. One limitation of Raman spectroscopy is that signals 
obtained by normal Raman are usually very weak (Das & Agrawal, 2011). This would be 
problematic if low limits of detection are being assessed. Another limitation is that there is a 
possibility that if mixtures are being analysed then their spectra could overlap.  
 
2.5.1 Surface Enhanced Raman Spectroscopy (SERS) 
SERS enhances the Raman scattering signal by adsorbing molecules onto a roughened metal 
surface. This enhancement method was first studied in 1977 by Jeanmaire et al and Albrecht 
et al. Two mechanisms were proposed for the observed enhancement: 
- Electromagnetic enhancement, associated with the roughened metal surface 
(Jeanmaire et al., 1977) 
- Chemical enhancement, due to the electronic coupling of molecules adsorbed on 
the roughened metal surfaces (Albrecht et al., 1977) 
 
Electromagnetic enhancement works on the basis that there is excitation on the metal 
surface by the surface plasmons resulting in resonance (Chen et al., 2010). The chemical 
enhancement works due to the analyte forming bonds with the metal surface creating new 
electronic states due to the different formation of the bonds (Chen et al., 2010).   
 
The signal obtained by normal Raman scattering is normally weak, hence why the SERS 
technique is preferred (Das & Agrawal, 2011). This technique yields information about the 
molecular interaction between the surfaces, allowing low concentrations of the analyte to 
be detected. It also increases the intensity of the Raman signal up to 104 to 106 fold enabling 
faster and higher accuracy detection of samples (Zeisel et al., 1998). SERS has previously 
been used to detect and identify explosives, narcotics in trace amounts and molecules of 
biological interest (Andreou et al., 2013).  
 
SERS allows an enhancement in the Raman signal due to the surface plasmons of silver or 
gold being excited resulting in an increase in the electric field that surrounds the metal 
(Andreou et al., 2013). A SERS colloid is a system where finely divided particles remain 
dispersed in a continuous matrix (White & Hjortkjaer, 2014). Smooth nanoparticle spheres 
do not offer a significant enhancement, these nanoparticles need to be aggregated to 
generate ‘hot spots’ where the enhancement increases significantly. For example, the 
addition of chloride or nitrate ions leads to aggregation which increases the SERS signal. 
Therefore the key to obtaining an optimised SERS method depends on the concentration of 
the colloid along with the concentration of an aggregating agent. The role of the aggregating 
agent is to create aggregates that generate ‘hot spots’ which is where you get the surface 
enhancement. Chen et al (2010), used sodium chloride as an aggregating agent to analyse 
caffeine using SERS. Other aggregating agents have been used in the literature for example, 
sodium borohydride (Creighton, 1979) and hydroxylamine phosphate (White, 2014).   
 
 
One of the main limitations of developing a colloidal system is the ability to produce a 
colloid that has good batch-to-batch reproducibility and good stability (White & Hjortkjaer, 
2014). To make this technique acceptable in real-world applications it needs to be: 
- Reproducible with a minimum of 10% variation between substrates and 
laboratories. 
- Stable for at least 8 months from fabrication 
- Provide an enhancement factor of at least 106  
- Acceptable cost 
 
There are a number of different synthetic routes that are taken to develop colloidal systems 
with the preference being the use of silver colloids. There are different methods that have 
been used to develop and produce silver colloids (White & Hjortkjaer, 2014). Creighton 
developed a method using reduced silver nitrate with sodium borohydride however the 
stability of the colloid caused problems. Another method that has been used is a silver 
nitrate system using sodium citrate as the reducing agent (Lee and Meisel, 1982). Their 
method has been used extensively but the data present indicated that there were problems 
with reproducibility of batches both within and between labs. A number of attempts have 
been made to stabilise a silver colloidal system with the use of sodium citrate to produce 
reproducible colloids nevertheless more problems have been established. Kier, et al (2002) 
used borohydride reduction of silver nitrate with the addition of trisodium citrate, they 
found that when observing the UV spectral data it indicated that there was a wide range of 
particle size. The interaction between the analyte and the silver surface is complex and the 
addition of stabilising ions can be undesirable as this could modify the particle surface and 
can contribute to difficulties in the aggregating process which is a key step in the SERS 
procedure (White & Hjortkjaer, 2014).  
 
When a colloid is produced the silver metal particles have a charge on their surface which 
keeps them dispersed in a medium (White & Hjortkjaer, 2014). The reason these colloids 
become unstable is because they lose their charge over a period of time, resulting in the 
colloid becoming unstable and the metal particles dropping out of solution. A stable silver 
colloid with strong scattering has been produced by reducing silver nitrate with 
hydroxylamine phosphate (White & Hjortkjaer, 2014). The rapid introduction of the silver 
nitrate solution to the reducing agent is a critical factor in producing good batch-to-batch 
reproducibility. This method has been used for over two years for the SERS detection of 
fraudulent use of fuels which is a further testimony to the reproducibility and long shelf life 
of the colloid. As this method only uses very small quantities of inexpensive reagents 
confirming that this HPAg colloid meets all of the requirements that are stated above. 
 
Chen et al (2010) found that when analysing caffeine using SERS there was better 
enhancement when using the silver colloid and the aggregating agent (NaCl) in comparison 
to when the colloid was used on its own. They found that when using low concentrations of 
the silver colloid on its own the Raman bands are not evident until it reaches a maximum 
concentration of 1.75x10-4 M. This was also seen when analysing caffeine with the 
borohydride-reduced silver colloid and the NaCl aggregating agent. They were successfully 
able to analyse caffeine and could conclude that the concentration of the colloid and the 
concentration of the aggregating agent plays an important role in SERS spectroscopy.  
  
There has been an increase in the number of drug-related cases in emergency rooms 
appearing globally. In 2009, America found that the number of these cases (4.6 million) 
almost doubled that in 2004 (2.4 million) (Farquharson et al., 2011). In order to determine 
drug abuse and drug overdose screening and confirmation techniques are required 
(Farquharson et al., 2011). Immunoassay kits are used for screening by providing drug 
identification, however they are subject to a number of interferences leading to false 
positives (Farquharson et al., 2011). The use of GC-MS is commonly looked on to provide 
the confirmation and quantification of the drugs in question. However routine identification 
can be time-consuming (Schauer et al., 2005) which will in turn delay diagnosis.  In order to 
meet the increased number of drug cases in emergency rooms Farquharson et al (2011) 
have investigated the ability of using SERS to detect and identify a number of drugs in saliva.  
 
Farquharson et al (2011) analysed 152 drugs ranging from illicit drugs, prescription, over-
the-counter and their metabolites using SERS with fused gold colloids. They successfully 
developed a method for measuring drugs in saliva by combining solid-phase extraction to 
separate the drugs and then used a SERS-active capillary to conduct the final analysis. Their 
method allowed the detection and identification of cocaine (50 ng/mL), PCP (1 µg/mL), 
diazepam (1 µg/mL) and acetaminophen (10 µg/mL). The analysis was performed in less 
than 10 minutes.      
 
Farquharson et al (2005) have also analysed the detection of 5-fluorouracil in saliva using 
SERS. This study was conducted because being able to determine the dosage of 
chemotherapy drugs remains a challenge in the treatment of cancer due to overdosing. 
Being able to identify different drugs in saliva is increasingly important as it will enable 
testing that can be done quickly and effectively to determine what substances have been 
taken especially when someone is suspected to be under the influence whilst driving.  
 Current clinical lab analysis of drugs in overdose patients involve extensive sample 
extraction and GC-MS analysis which can take as much as one hour to perform as previously 
stated. In order to overcome this limitation Shende et al (2005), investigated metal-doped 
sol-gels to separate the drugs and their metabolites from saliva and then generate SERS 
spectra. This allowed them to analyse cocaine, its metabolite benzoylecgonine, and several 
barbiturates in concentrations of µg/mL. 
 
Andreou et al (2013) conducted a study into detecting drugs of abuse namely 
methamphetamine in saliva using SERS and microfluidics. However methamphetamine has a 
relatively low affinity for silver and so in order for SERS detection to be possible 
methamphetamine was chemically modified to enable it to bind to the substrate. A 
microfluidic device was developed that enabled the transportation and aggregation of SERS 
active silver nanoparticles that aided in the detection of methamphetamine in saliva. Their 
results provide evidence for a rapid detection method that can be used to identify narcotics 
in biological fluids (saliva) which can potentially be used in other applications such as toxin 
detection and groundwater analysis.  
 
Pavel et al (2002) looked at the analysis of caffeine at different pH values using a sodium 
citrate reduced Ag colloid which was used along with a NaCl solution to aggregate the 
colloid dispersion. They concluded that the flat orientation of caffeine attached to the Ag 
through the electrons and the lone pair of the N9 atom for neutral and basic values. When 
the caffeine was in at an acid pH value it was absorbed onto the Ag through one or both of 
the oxygen atoms. When caffeine was neutral or basic it absorbed onto the Ag surface 
through the electrons and the lone pair of the nitrogen atoms. When they compared the 
SERS spectrum of caffeine on Ag sol (pH 2.5) to the FT-Raman spectrum of solid anhydrous 
caffeine they noticed small shifts in the bands. They concluded that both electromagnetic 
and chemical mechanisms are involved in the interaction of caffeine and the Ag colloid due 
to large differences in the relative intensities of some of the bands, in particular carbonyl 
stretching. However, the change in the SERS pattern indicates that the electromagnetic 
mechanism is the dominant one.  
 
 2.6 Quantitative methods 
Using SERS for quantitative analysis remains a challenge because of (a) difficulties 
associated with the production of reproducible SERS active substances, (b) the complex 
spatial and temporal characteristics of SERS substrates, (c) the strong dependence of the 
SERS enhancement of the distance between the analyte and the SERS substrate, and (d) 
variations of SERS enhancement with the surface coverage of the analyte on the substrate 
(Zhang et al., 2005). Quantitative concentration analysis using SERS must contend with 
variations that are produced by changes in excitation. In order to correct for these variations 
an internal or external standard is used to calibrate the correlation. Zhang (2005) describes 
a new isotopically edited internal standard (IEIS) that enables quantitative SERS 
measurements over a wide range in concentration with accuracy and reproducibility. They 
use deuterated rhodamine 6G (R6G-d4) as an internal standard to analyse rhodamine 6G 
(R6G) with a silver colloid. They found that some of the Raman bands of R6G-d4 shifted with 
regards to their location in R6G. This is consistent with the mass of deuterium being higher 
in comparison to hydrogen. They concluded that their method has shown to be reliable and 
reproducible.  
 
One of the draw backs for using SERS as a quantitative method is that there can be 
variability so an internal standard would be used. An internal standard (IS) is a chemical 
substance that is added to a standard/sample improving the precision of quantitative 
analysis. An IS is a known concentration of a substance that is present in every sample that 
is analysed. The IS then can be used for calibration by plotting the ratio of the analyte to the 
internal standard therefore aiding quantitation. An internal standard behaves similarly to 
the analyte being analysed but is able to provide a signal that can be distinguished from the 
analyte. Ideally, factors that affect the signal of the analyte will affect the signal of the IS. 
Therefore the ratio of the signal from the analyte and IS will exhibit less variability than the 
analyte signal alone.  
 
Katainen E (2007) looked at quantifying amphetamine in seized street samples using Raman 
spectroscopy. They used sodium dihydrogen phosphate as their internal standard and were 
able to quantify ten independent amphetamine seizures. Sodium dihydrogen phosphate 
was used as an IS because it possesses a characteristic band at 880 cm-1. When looking at 
the amphetamine spectrum it has three bands between 1050-950 cm-1 and a signal free area 
around 880 cm-1. They concluded that Raman spectroscopy appears to be a potential 
candidate for quantitation of illicit drugs and adulterants.  
 
Alvi et al (2011) and Perera et al (2010) both use internal standards when analysing caffeine 
using the HPLC. Alvi et al (2001) used an internal standard, antipyrine for their analysis when 
they compared the peak area of caffeine and the IS to determine the quantitation using a 
calibration curve. Perera et al (2010) used benzotriazole as there IS. They again used a ratio 
of the peak height of caffeine and benzotriazole in order to determine the concentration of 
unknown samples (Perera et al., 2010).  
 
2.7 Oral fluid  
The two main biological fluids used to detect drugs are blood and urine; however the 
methods to obtain these fluids are invasive. Substances can be detected in oral fluid for a 
short period of time, normally 12-24 hours after the consumption. Therefore using oral fluid 
for detecting recent drug use is suitable especially for clinical toxicology and for roadside 
testing (Bosker & Huestis, 2009). Oral fluid is produced by a number of glands and consists 
of 99.5% water and trace amounts of proteins. The fact saliva is mainly water makes it easy 
to analyse (Farquharson et al., 2011). Saliva is increasingly being used as an alternative in 
pharmacokinetic studies, therapeutic drug monitoring and investigating the use of illicit 
drugs. Particular interest has been expressed by law enforcement agencies for road side 
testing of potentially intoxicated drivers (Kintz & Samyn, 1999). In 2012 the UK government 
announced a new drug driving offence; if specific controlled drugs are in the body over a 
certain acceptance limit regardless whether they are impaired they will be committing an 
offence. In 2015 8 prescribed drugs and 8 illicit drugs were added into the new regulations, 
amphetamine was added April 2015. The Home Office were developing a roadside screening 
device based on SERS that is capable of analysing drugs in oral fluid for the past 10 years, 
however this is no longer a Home Office project (Butcher, 2015). There are currently two 
drugs that are analysed at the roadside; cocaine and cannabis and the test is by Securetec. 
Securetec provides products for the detection of addictive and dangerous substances; one 
of their products is DrugWipe® S. It has been developed for roadside testing of cannabis and 
cocaine. The detection limit of the active substance Δ9-THC in saliva is 10 ng/ml. It is 
claimed to be one of the best drug tests in the world with low sampling volume.  
 
The main limitations of using saliva to analyse the presence of drugs is that the amount of 
matrix collected is smaller in comparison to urine and the level of drugs in urine is a lot 
higher than in saliva; due to the drugs being concentrated by the kidneys (Kidwell et al., 
1998). However due to the advances in analytical instrumentation all the requirements for 
forensic testing can be met with saliva as well as urine and blood. Oral fluid has been found 
to be suitable for the detection of drugs that have been recently taken and is easily available 
for collection (Lund et al., 2011). Another advantage of using oral fluid to detect drugs is 
that the samples can be collected under close supervision to prevent substitution or 
adulteration, which is a problem when sampling urine (Øiestad et al., 2007). 
Table 3: Different analytical techniques that have detected drugs in oral fluid 
 
 
Drug(s) detected in oral 
fluid 
Analytical 
technique 
Extraction 
Technique 
Internal Standard 
(examples) 
Øiestad  
et al 
(2007) 
Amphetamine, Cocaine, 
Codeine, Diazepam, LSD, 
MDA, MDMA, 
Methamphetamine, 
Methadone, Morphine, 
THC, 
Zopiclone  
LC-MS-MS None Deuterated Internal 
Standards  
 
Morphine-d3, 
Amphetamine-d3, 
Methamphetamine-
d11, MDMA-d5, 
THC-d6 
Badawi  
et al 
(2009) 
Morphine, Amphetamine, 
MDA, MDMA, 
Methamphetamine, 6-
Acetlymorphine, 7-
Aminonitrazepam, 
Tramadol, Cocaine, 
Clonazepam 
UPLC SPE  Deuterated Internal 
Standards  
Gunnar et 
al (2005) 
THC, Diazeopam, Cocaine, 
Methadone, Codeine, 
Oxazepam  
GC-MS SPE Deuterated 
analogues  
 
THC-d3, 
Diazeopam-d5, 
Cocaine-d3, 
Methadone-d9 
Alvi et al 
(2011) 
Caffeine  HPLC None Antipyrine  
Perera et 
al (2010) 
Caffeine, Paraxanthine  HPLC LLE Benzotriazole 
 
 
Different analytical techniques for analysing drugs of abuse in saliva are being explored. 
Table 3 summarises the different techniques and the drugs detected. Liquid 
chromatography–tandem mass spectrometry (LC-MS/MS) was used by Øiestad et al (2007), 
they found that the sample preparation was easy, the method required no derivatisation 
and there was only a short analysis time. However several of the components co-eluted and 
could not be differentiated. Lund et al (2009) and Badawi et al (2009), found that when 
switching to ultra-performance liquid chromatography (UPLC) the run time was shorter and 
satisfactory separation was achieved. Only a limited amount of oral fluid is available for drug 
analysis, therefore it is crucial to have a multicomponent method usually with a low limit of 
detection. Gunnar et al (2005), reported a procedure for the identification, screening and 
quantitation of 30 drugs of abuse in saliva using GC-MS with solid-phase extraction (SPE) 
and derivatisation. Wood et al (2005) and Mortier et al (2002) both validated a method for 
the detection of the most prevalent illicit drugs and their metabolites in saliva using LC-
MS/MS; however neither THC nor benzodiazepines were detected using these methods.   
 
Wylie et al (2005) used GC-MS and LC-MS-MS to detect 49 licit and illicit drugs in oral fluid. 
This provided a method that was sensitive and selective for the analysis of these drugs. 
Initially Δ9-THC was included in the analysis, but a white residue was obtained in the fraction 
containing Δ9-THC which caused interference. Therefore this method was unable to analyse 
Δ9-THC.  
 
Wood et al (2005), provided a study looking into quantification of amphetamine in oral fluid 
using LC-MS/MS. They found that using the traditional confirmatory assay (GC-MS) was 
problematic due to the limited amount of sample. They produced a method that was simple 
and rapid which exploits the specificity of tandem spectrometry in order to obtain a 
sensitive assay. This allowed the quantification of 6 commonly abused amphetamines in oral 
fluid by using a clean-up method followed by LC-MS/MS. This developed method provided 
sensitivity, speed, simplicity and reliability over the traditional GC-MS method. This LC-
MS/MS method was able to detect and quantify amphetamines found in oral fluids that had 
been collected from people suspected of driving under the influence of drugs which were 
previously undetected by GC-MS.  
 
It can be seen in the literature that a lot of research is going into the analysis of drugs in oral 
fluid and the ability to detect and quantify. When looking at detecting caffeine in saliva a lot 
of previous research has gone into developing a method with the use of an extraction 
technique.  
 
2.8 Liquid-liquid extraction  
There are different solvents for liquid-liquid extraction that will successfully extract caffeine 
from various sources. The most commonly used solvents are chloroform, methyl chloride, 
ethyl acetate and carbon dioxide (Mumin et al., 2006). Mumin et al, (2006) successfully 
extracted caffeine from green tea, black tea and coffee using a liquid-liquid extraction and 
interferences were removed by employing solid-phase extraction. The absorbed caffeine 
was then eluted twice with 2 mL of chloroform and dried. They were then analysed on the 
HPLC for quantitation and were able to quantify the caffeine.  
 
Shende et al (2005) developed a SERS method for the analysis of several barbiturates in 
saliva. They analysed the saliva samples directly and found that the resultant spectra were 
very similar and concluded that a chemical separation might be required to extract the drug 
from saliva. Shende et al (2005) continued to develop a method that separated drugs from 
saliva. When analysing caffeine, phenobarbital and cocaine they found that adding 1 M 
sulphuric or acetic acid, heat and sonication successfully separated the drugs from saliva. 
They also concluded that this extraction technique was sufficient enough to degrade the 
saliva proteins allowing the drug in question to bind to the SERS-active metal surfaces 
without any interference from the proteins.  
 
Øiestad et al (2006) used a LLE technique to analyse drugs in oral fluid. Their samples were 
extracted by adding a ethylacetate:heptane solution, mixing for 10 minutes and the 
centrifuging. This enabled them to analyse a large number of drugs including low-dose 
benzodiazepines. Perera et al (2010) also used an extraction technique to extract caffeine 
from saliva. The solvent that was used in this study was ethyl acetate, the samples were 
mixed for 5 minutes and then centrifuged.  
 
2.9 Summary 
As can be seen by the literature there are various methods that can be used to analyse 
different legal high substances and a lot of these legal high substances contain the 
adulterant caffeine. The use of Surface-Enhanced Raman Spectroscopy is one that has 
recently started drawing interest with regards to analysing drugs due to its low limit of 
detection. Saliva testing for drugs is a developing area and that SERS offers the potential to 
provide a rapid portable analysis. This work will focus on caffeine and metabolites as model 
compounds to develop a procedure but once developed the technique can be applied to 
other drugs including NPS. SERS will be looked at within this study to analyse caffeine found 
in oral fluid. 
 
2.9.1 Aims and Objectives 
The main aim of this project is to provide an analytical method for the analysis of caffeine in 
oral fluid. This will be done by using Surface-Enhanced Raman Spectroscopy as the screening 
technique coupled with HPLC-DAD as a confirmation technique. A SERS method will be 
developed, optimised and validated for the analysis of caffeine in methanol, looking at 
different instrumental parameters eg filter, acquisition time and hole. In addition the 
parameters around the concentration of the silver colloid and aggregating agent will be 
investigated. This established method will be applied to caffeine in water and subsequently 
caffeine in saliva. An optimised HPLC method will be developed and validated for the 
quantification of caffeine. These methods will then be applied to the analysis of caffeine in 
oral fluid. 
3. Materials and Methods 
 
3.1 Instrumentation  
3.1.1 High-performance liquid chromatography (HPLC) 
The chromatographic system used was Merck Hitachi LaChrom diode-array detector L-7455 
with an Interface D-700, LaChrom column oven L-7350 and a solvent degasser L-7612. The 
detector wavelength used was 245 nm. A Zorbax ODS C18 column (25 cm x 4.5 mm x 5 µm) 
was used for the separation of the analytes. The mobile phase used was methanol.  
 
3.1.2 Raman Spectroscopy 
The system used was a Horiba Jobin Yvon Labram. A 532 nm green laser was used as Raman 
excitation, using these settings: filter 1%, hole 1000 µm, slit 100 µm and scan range of 200-
1700 cm-1. For each Raman scan, the acquisition time was 20s and 2 scan cycles (unless 
stated otherwise). The microscope was used for powders and the cuvette attachment was 
used for solutions using glass cuvettes.  
 
The software KnowItAll which is used for interpretation, identification, verification and 
classification of spectra was used to interpret the spectrum  
 
3.1.3 UV-Vis 
The absorption spectrum was recorded using a Shimadzu UV-Vis spectrophotometer UV-
1650PC over a wavelength range of 300-700 nm using a medium scan speed and the light 
source at 295 nm and plastic cuvettes.  
 
3.2 Chemicals and sample preparation 
3.2.1 Chemicals 
Anhydrous caffeine powder was supplied by Sigma Chemical co. The silver nitrate (AgNO3), 
sodium hydroxide (NaOH) hydroxylamine phosphate, reducing solution (Na2SO3 and KCNS), 
dilute phosphoric acid, and potassium permanganate were used directly without any 
purification. All the solutions were prepared in deionised water (15 MΩ) and the caffeine 
was prepared in methanol. All samples and solvents were acquired from Sigma Aldrich at 
HPLC grade with respect to the solvents.  
 3.2.2 Colloid preparation  
The sodium hydroxide (NaOH) was made by adding 1.335 g of NaOH to 100 mL of water. 
This was then diluted down to a 1 in 100th dilution to make a concentration of 3.300x10-3 M 
(working solution) which was freshly made. Silver nitrate (AgNO3) was made by adding 140.3 
mg to a volumetric flask and 100 mL of water was added to give a concentration of 1.000 x 
10-2 M. 20.4 mg of hydroxylamine phosphate was added to a vial and then topped up with 4 
mL of water to give a concentration of 2.54 x 10-5 M.  
 
The silver colloid for the surface enhanced Raman spectroscopy (SERS) was prepared by 
adding 4.5 mL of the working NaOH solution to a vial. 100 µl of Hydroxylamine phosphate 
was then added to the vial and rotated slowly for a few seconds. 500 µl of a 1x10-2 M AgNO3 
solution was added quickly and again rotated slowly for a couple of minutes. This method 
was based on the work of White and Hjortkjaer (2014).  
 
UV-Vis spectrometry was used to determine the maturity of the colloid. The UV-Vis spectra 
were obtained by pipetting 0.06 mL of the colloid into a 4 mL disposable polystyrene 
cuvette and 3 mL of water was added.  
 
3.2.3 SERS method 
The colloid was then left for a month in order for it to mature. The aggregating agent 
sodium chloride (NaCl) was used directly without any purification and was 0.1 M 
concentration. 100 µl of the sample was added to the cuvette followed by 100 µl of the 
aggregating agent and the sample was inverted a couple times. Then 500 µl of the colloid 
was added and inverted again. The sample was then analysed on the Raman immediately 
using the cuvette attachment unless stated otherwise. All spectra were baseline corrected 
and 4 replicates were made.  
 
3.2.4 Preparation of solutions used for Liquid-Liquid Extraction  
The reducing solution (Na2SO3 and KCNS) was made by adding 5 g of Na2SO3 and 5 g KCNS to 
100 mL of water. Phosphoric acid was made by diluting 15 mL syrupy phosphoric acid to 85 
ml of water. 25 g of sodium hydroxide was added to 75 mL of water. 1.5% potassium 
permanganate was made by adding 0.75 g with 49.25 mL of water. 
 
3.2.5 Liquid-Liquid Extraction procedure  
1 mL of sample was added to a separating funnel and 500 µL of potassium permanganate 
was added. The separating funnel was inverted for 1 minute. Then 1 mL of the reducing 
solution (Na2SO3 and KCNS) was added and inverted. 100 µL of diluted phosphoric acid and 
100 µL sodium hydroxide was added to the funnel and inverted. 5 mL of chloroform was 
added to the separating funnel, inverted for 5 minutes and left for the layers to separate for 
20 minutes. After 20 minutes the bottom chloroform layer was filtered through fluted filter 
paper and into a vial. The funnel stem was rinsed with 300 µL of chloroform and drained 
through the filter paper. The filtered paper was then washed with 300 µL of chloroform. The 
aqueous layer was then re-extracted with 4 mL of chloroform. Both the extractions were 
added together, blown down to dryness using nitrogen and reconstituted in 1 mL of 
methanol. 
 
4. Results and Discussion 
 
4.1 Analysis of caffeine using Raman Spectroscopy  
One of the advantages of using Raman spectroscopy is its ability to detect the presence of 
substances in aqueous solutions. It provides a finger print region which can be used to 
identify and quantify different substances. Figure 2 shows the Raman spectrum of caffeine 
powder along with the structure of caffeine. Caffeine has two rings that are fused these are; 
pyridine ring and the imidazole ring. On the pyridine ring two amide groups and two tertiary 
amine groups can be found. Whereas, the imidazole ring has one amide group, one tertiary 
group and an alkene group.  
 
  
Figure 2: Raman spectrum of caffeine powder using 100% filter, 300 µm hole, acquisition 
time of 10 seconds and 2 scan cycles. A) 553 cm-1 B) 1325 cm-1 C) 1600 cm-1 . Baseline 
corrected  
 
Table 4 shows the different peaks in the Raman spectrum and their assignment. There are 
three key bands that can be used to identify caffeine at 553 cm-1, 1325 cm-1 and 1600 cm-1 
which can be assigned to the pyridine ring, imidazole trigonal ring stretching and C=C stretch 
respectively.   
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Table 4: Assignment of the caffeine peaks (figure 2) using Chen’s (2010) assignment table  
Raman  
cm
-1
  
Assignment of Caffeine Powder  Assignment of Caffeine in Solution  
441m N-C-C   
481ms C-N-C   
553vs O=C-N or pyridine ring O=C-N or pyridine ring 
609vw O=C-N   
641ms O=C-N   
696w C=O  
738m O=C-C  
798m N-C-H  
926m Imidazole ring   
973w Pyridine ring   
1020m  N-CH3 stretch   
1067m In plane C-C  
1130vw C-N   
1187vw C=N stretch  
1238m C-N stretch   
1283m  C-N stretch  
1325vs Imidazole trigonal ring stretching  Imidazole trigonal ring stretching 
1404w C-N antisymmetric stretching   
1450vw C=N stretch  
1551vw C-C stretch  
1600m C=C stretch  C=C stretch 
1657mw C=O stretch  
1698ms  C=O stretch  C=O stretch 
vw – very weak, w – weak, m – medium, ms – medium strong s –strong, vs – very strong 
Figure 3 shows the Raman spectrum of caffeine in an aqueous solution. It demonstrates that 
Raman spectroscopy is capable of analysing aqueous solutions.  
 
 
 
 Figure 3: Raman spectra of 10 mg/mL caffeine in water (green) and spectra of blank water 
(orange) using 100% filter, 1000 µm hole, acquisition time of 10 seconds and a scan cycle of 
2. Baseline corrected 
 
The spectrum of the caffeine powder shows similarities to the spectrum of the caffeine in 
aqueous solution. There is a strong peak that can be seen in Figure 2, table 4 at 1336 cm-1 
which can be assigned to the imidazole trigonal ring stretching. Some other peaks that can 
be used to distinguish caffeine are the two at 1604 cm-1 and 1688 cm-1 which are 
responsible for the vibrational bands of C=C stretch and C=O stretch respectively. The 
spectrum of caffeine in water is weaker which can be seen by the lower intensities and the 
baseline appears to be nosier. A glass cuvette was used to analyse caffeine in water, figure 3 
demonstrates that there is no interference from the glass. Figure 3 also shows that the 
additional peaks in the caffeine and water spectrum are due to the caffeine and not the 
water. This is confirmed by comparing a water blank where it is evident that there are no 
peaks present. Raman spectroscopy can be used to quantify solutions and therefore be used 
to determine the concentration of an unknown sample.  
 
 
 
 
 
0
1000
2000
3000
4000
5000
350 550 750 950 1150 1350 1550 1750
R
am
an
 In
te
n
si
ty
 
Raman Shift/cm-1 
1
6
0
4
cm
-1
 
1
6
8
8
cm
-1
 
1
3
3
6
cm
-1
 
4.2 Quantitative Raman spectroscopy 
A calibration curve was produced by using the peak height of caffeine found at 1336 cm-1 
against the concentration of known standards. The results are shown in table 5 and figure 4.  
 
Table 5: Calibration results for the different caffeine standards  
Concentration 
(mg/mL) 
Mean Peak height of 
Caffeine 
(n=8) 
Standard Deviation 
1 251.04 25.18 
3 650.26 174.10 
5 1002.84 418.01 
7 1732.92 88.59 
10 2222.54 536.74 
 
 
 
Figure 4: Calibration results of the different caffeine standards showing the calibration 
equation (n=8, error bars are ±1SD) 
 
The Raman signal at 1336 cm-1 increases with the increasing concentration of the solution. 
This demonstrates that the Raman signal is directly proportional to the number of molecules 
y = 227.5x - 11.075 
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in solution over the concentration range. Therefore it is possible to develop a quantitative 
method.  
 
 
4.3 Analysis of solid caffeine tablets using Raman spectroscopy  
Caffeine tablets were provided to test the quantitative method by identifying whether 
caffeine is present and quantify the caffeine concentration. One tablet was dissolved in an 
aqueous solution and analysed using the Raman method. The solubility of caffeine in water 
at room temperature is 2g / 100mL. The caffeine tablet contains 200 mg of caffeine; it was 
dissolved in 10 mL of water and put in the sonic bath for 10 minutes to help dissolve the 
caffeine fully. Figure 5 shows the spectrum of the caffeine tablet.  
 
  
Figure 5: Caffeine tablet in water using 100% filter, 1000 hole, acquisition time of 10 seconds 
and a scan cycle of 2. Baseline corrected  
 
Comparing figure 3 (10 mg/mL spectrum) and figure 5 (above) it is evident that caffeine is 
present as it has the same peak at 1336 cm-1 that is present in the caffeine standards (figure 
3). It also has other caffeine peaks present, the two peaks found in the caffeine standard at 
1604 cm-1 and 1688 cm-1 can be seen in the caffeine tablet but the peaks are not separated. 
1336 cm-1 is a good band to use as it remains sharp. Table 6 shows the different correlation 
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coefficients when the unknown caffeine tablet was compared to the 5 caffeine standards 
used for the calibration curve. Looking at the correlation coefficient it shows that the 
unknown caffeine tablet has a correlation coefficient of 0.996 when compared to the 
caffeine standards. The correlation coefficients were obtained by exporting the spectra into 
Excel and using the correlation coefficient function in Excel. This suggests that the unknown 
caffeine spectrum has the same pattern of peaks that the standards have. Whatever else 
might be in the tablet isn’t interfering with the caffeine spectrum as there is good 
correlation match to the standards.   
 
Table 6: Correlation coefficient of the unknown caffeine tablet (U) compared to the 
standards of known concentration.  
U compared to standards 
(mg/mL) 
Correlation 
coefficient 
U:10 0.974 
U:7 0.983 
U:5 0.988 
U:3 0.996 
U:1 0.995 
  
By looking at the lower concentrations of caffeine (1 mg/mL) using Raman spectroscopy it 
may be difficult to determine if caffeine is present in a sample. Surface-Enhanced Raman 
Spectroscopy is capable of analysing samples at a much lower concentration. In order to use 
Surface-Enhanced Raman Spectroscopy, a SERS substrate is required. UV-Vis was used to 
characterise and establish that the colloid is being produced in a repeatable way as only 
small volumes were prepared at a time.  
 
4.4 Preparation of the silver colloid  
Using a method developed by Peter White (2014), silver colloids were produced using the 
method stated previously (section 3.2.2) In order to produce a stable colloid the addition of 
the silver nitrate solution has to be done very quickly as it is a critical factor in the chemical 
reaction. After the addition of the silver nitrate, the colloid solution turns a dark brown 
colour. Once the colloid had matured it produces a straw coloured solution (Fig 6a). The UV-
Vis spectra can be used to determine different features of colloid such as the size of 
particles and its degree of aggregation. It has previously been established that the number 
of particles in the solution is proportional to the absorbance (White & Hjortkjaer, 2014). A 
broadening of the bandwidth indicates a wider particle size distribution. Any aggregation of 
a colloid is also indicated by a decrease in absorbance and the appearance of a second band 
at a longer wavelength this can be seen in figure 7 when looking at TP14.    
 
A 
 
B 
 
C 
 
Figure 6: A) photograph of a stable colloid (after 3 months), B) and C) photograph of two 
colloids that show different stages of a ‘crashed’ colloid  
 
Within the colloid solution the silver particles have a charge on their surface; this charge is 
what keeps the particles dispersed. Figure 6b and 6c show images of two colloids that have 
become unstable at different degrees. Figure 6b had gone from being a straw colour to a 
green solution and figure 6c the silver particles have ‘dropped out of suspension’; the 
particles were visible along the bottom of the vial. This shows that there is batch to batch 
variability and if the colloid isn’t prepared in the exact same way then some of the colloids 
will ’crash’. One explanation for this behaviour is that the colloid has become unstable due 
to the loss of charge from the silver particle surface. This could be caused by two things; the 
dissolution of the ion onto the aqueous solution or the migration of the silver surface ions to 
the container wall (White & Hjortkjaer, 2014). Looking at Figure 6c the silver particles have 
precipitated (crashed) which indicates that the colloid has a short shelf life. 
 
Looking at the UV-Vis shown in figure 7 a sharp narrow peak indicates a good quality colloid 
with narrow nanoparticle size distribution. Table 7 shows the height of the colloid peak and 
its half height.  
 
Table 7: The UV-Vis absorbance of the peak height and the peak width of 3 colloid samples 
and 1 diluted colloid sample 
Colloid Sample λ max (nm) Peak width at 
half height 
(nm) 
KW9 397 55 
KW18 397 55 
TP14 393 40 
KW9 diluted 50% 397 57 
  
The peak width shows that colloid KW9 and KW18 has matured as it shows a bandwidth of 
around 51 nm (White & Hjortkjaer, 2014). When looking at KW9 and KW18 the colloid is 
only a month old whereas TP14 is four months old suggesting it has reached its full maturity. 
After the initial preparation of the colloid, there is a decrease in the bandwidth. The ageing 
process resulted in the stabilisation of the colloid and its bandwidth. It was observed that 
these changes occurred more rapidly within the first 4 weeks of the colloid preparation and 
then started to stabilise to produce a colloid which meets the four standards that have been 
set. Figure 7 shows the spectra of the 1 month old colloid, 4 month old colloid and the effect 
of diluting the colloid by 50%.  
 
 Figure 7: UV-Vis absorbance spectrum of the silver colloids: KW18 (1 month old colloid), TP14 
(4 month old colloid) and the colloid diluted by 50% (KW9 1 month old) 
 
Figure 7 demonstrates the effect of leaving the colloid for a period of time in order for it to 
mature. When looking at the 50% dilution it is evident that the absorbance is considerably 
lower than KW18 due to there being less colloid nanoparticles in the sample. Therefore 
there is a decrease in absorbance as fewer particles are present. When looking at TP14 the 
absorbance is higher as it has had a longer time to mature. TP14 also suggests that there is 
some aggregation as there is a hump around 480 nm. Table 8 shows the effect of diluting 
the colloid against the absorbance.  
 
Table 8: Absorbance values for the diluted colloid using 295 nm wavelength                                                            
Percentage 
dilution (%) 
Mean 
(n=3) 
Standard Deviation 
 
0 0 0 
25 0.053 0.0040 
50 0.118 0.0070 
75 0.174 0.0180 
90 0.197 0.0290 
100 0.255 0.0102 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
310 360 410 460 510 560
A
b
so
rb
an
ce
 
Wavelength/nm  
KW18
TP14
50-50 dilution
 Figure 8: The relationship between the absorbance and the dilution of the colloid (n=3, error 
bars are ±1SD, 295 nm wavelength) 
 
As can be seen from figure 8 the absorbance of the colloid is directly proportional to its 
percentage dilution. The direct proportional relationship between the absorbance and 
concentration which is demonstrated in Figure 8 is the Beer-Lambert law.  
  
 
 
4.5 Optimising Surface-Enhanced Raman Spectroscopy (SERS) for the analysis of caffeine in 
methanol 
To optimise a SERS method that is able to analyse caffeine in methanol a number of 
parameters can be altered. The different instrumental parameters that can be changed on 
the Raman spectrometer range from the filter, the hole, the acquisition time and the slit etc. 
The filter protects the sample from the emitted light and reduces the scattering of the laser. 
The hole is changed when using the confocal microscope; it allows the depth of field to be 
altered when looking at solids, with aqueous solutions the hole is not an important factor as 
it is important to collect as much of the scattered light to give a Raman signal. By changing 
the acquisition time it limits the amount of time the laser excites the sample for and 
controls the amount of time the light is collected. The longer the acquisition time the more 
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scattered light is collected. The slit width is crucial for the spectrometer’s performance. The 
slit width can be found at the entrance to the monochromator which projects the image 
onto the detector plane. The resolution and throughput is determined by the slit width. The 
bigger the slit means more light is going through the monochromator, which gives it a larger 
bandwidth but poorer resolution.    
  
To ensure that the signal from the SERS is due to surface enhancement some controls have 
to be taken into account. The controls are put in place to show that the enhancement of the 
signal is down to the use of the silver colloid and the aggregating agent rather than a 
conventional Raman spectra of caffeine. Figure 9 shows the different controls that were 
analysed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: (A) Raman spectrum of caffeine (25 µg/mL) when added to 600 µl of water (B) 
Raman spectrum of caffeine (25 µg/mL) when added to 500 µl of water and 100 µl of the 
aggregating agent (0.1 M NaCl). Baseline corrected   
 
As can be seen by figure 9 it is evident that there are no peaks when trying to analyse 
caffeine. The limit of detection of caffeine in water is not suitable for the levels of caffeine 
that can be found in saliva. Caffeine cannot be detected at these concentrations using 
normal Raman. Figure 3 shows a spectrum of a water blank where there are no peaks 
present. 
 
To demonstrate the effect that SERS has on the analysis of caffeine, caffeine was analysed 
using the Raman spectrometer along with SERS (Figure 10).  
 
 
Figure 10: (A) Raman spectrum of caffeine powder. (B) SERS spectrum of 25 µg/mL caffeine 
with silver colloid and NaCl (0.1 M) Baseline corrected   
 
Comparing figure 10a to figure 9 it is clear that there are peaks from caffeine present when 
using SERS at a level much lower than can be seen with normal Raman spectroscopy. This 
demonstrates that SERS is providing an enhancement compared to normal Raman.  
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Table 9 summarises the Raman frequencies of the conventional Raman and surface-
enhanced Raman spectrum of caffeine according to Chen et al (2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Raman  
cm
-1
  
Chen’s  
Raman cm
-1
 
SERS  Chen’s 
SERS 
Assignment  
441m 445m   N-C-C  
481ms 481ms   C-N-C  
  518m  505m N-C-C 
553vs 556vs 555vw 555vw O=C-N or pyridine ring 
588vw 609vw   O=C-N  
641ms 642ms   O=C-N  
696w 698w   C=O 
738mw 742s 722w 746vw O=C-C 
763vw 763vw    
798s 800s   N-C-H 
926s 925s   Imidazole ring  
973w 975w   Pyridine ring  
1020m  1020m 1014m 1014m N-CH3 stretch  
1067m 1070m 1080vw 1076vw In plane C-C 
1130vw 1133vw 1126w 1131w C-N  
1187vw 1189vw 1171m 1171m C=N stretch 
1238m 1239m   C-N stretch  
1283m  1283m   C-N stretch 
  1309m  C-N stretch 
1325vs 1327vs   Imidazole trigonal ring stretching  
1359s     
1404w 1409w 1360s 1363s C-N symmetric stretching  
  1414vw  CH3 symmetric bending 
1450vw 1456vw   C=N stretch 
1551vw 1551vw 1570m 1556w C-C stretch 
1596s 1600s 1616m  C=C stretch  
1657m 1656m 1647s  C=O stretch 
1698ms  1698ms   C=O stretch  
vw – very weak, w – weak, m – medium, ms – medium strong s – strong, vs – very strong 
Table 9: Peaks of caffeine with 
normal Raman 
 and SERS bands  
for silver colloid (Chen et al, 
2010).  
 
The differences between the Raman and SER spectra is not uncommon as it reflects the 
variations that occur between the surface interactions that enhance various vibrational 
modes to different extents (Shende et al., 2005). The two strong bands at 553 cm-1 and 1325 
cm-1 which can be seen in figure 10 are assigned to the O=C-N or the pyridine ring and 
imidazole trigonal ring stretching (Chen et al., 2010) which is in agreement with Chen et al 
(2010) who obtained bands at 556 cm-1 and 1327 cm-1 respectively. When comparing these 
peaks to the SERS spectrum there are small shifts between the frequencies (555 cm-1 and 
722 cm-1). However these bands considerably weaken when analysed using SERS as shown 
in table 9 for both the results obtained in this work and those of Chem et al (2010). Chen et 
al (2010) concluded that this was due to the planes of the pyridine ring being parallel to the 
silver surface. The bands at 1020 cm-1, attributed to the N-CH3, and 1404 cm
-1 (C-N 
stretching) in normal Raman were weaker in comparison to the peaks found at 1014 cm-1 
and 1360 cm-1. The assignment of bands using the software KnowItAll corresponds with the 
peaks assigned by Chen et al. The peak at 1360 cm-1 corresponds with a N-C-N symmetric 
stretching which is in agreement with the assignment from Chen at 1363 cm-1. The peak at 
1360 cm-1 on the SERS spectrum has a slight shoulder which has been matched to a methyl 
group. It is evident that the greatest enhancement is due to the C-N vibration which 
indicates that the C-N group interacts strongly with the silver surface (Chen et al., 2010) and 
the N-CH3 group is also in close proximity to the colloid surface.  
 
When looking to see what parameters produce the optimum spectrum for the analysis of 
caffeine, the caffeine peak at 1360 cm-1 will be used as it is provides a good response to 
SERS. This peak height along with the silver chloride peak at 200 cm-1 will be used to for the 
peak height ratio calculation. Table 10 compares the changes in parameter against their 
peak height ratio. It is evident that with regards to the time delay, when the sample was laid 
for 30 minutes it gave the best signal. This can be concluded as the peak height ratio is the 
highest suggesting it obtained the best signal.  
 
 
 
 
 
Table 10: The effect on the peak height ratio when the sample had been left (normalised) 
Time Delay Colloid peak 
height (200cm-1) 
Caffeine peak 
height 
(1360cm-1) 
Caffeine: 
Colloid peak 
height ratio 
 
Time Delay 
10 min  0.371108 1.0952465 2.95 
20 min  0.3755335 1.150011 3.06 
30 min 0.257068 1.107083 4.31 
40 min 0.3071225 1.1473995 3.73 
50 min  0.3692225 1.1426105 3.09 
60 min  0.3808825 1.1511975 3.02 
 
Using the optimum time the other parameters were optimised Table 11 shows these results. 
 
Table 11: The effect on the peak height ratio when changing the filter percentage and the 
acquisition time (normalised) 
 
When looking at table 11 it is evident that the filter percentage corresponds with the 
acquisition time. Comparing the spectra of the 1% filter to the different acquisition time it is 
evident that the best spectrum that is produced is when using a 20 second acquisition time. 
This can be concluded by looking at the caffeine:colloid peak height ratio, it is evident that 
the ratio for the 1% filter and 20 seconds acquisition time produces the best spectrum as 
the ratio is high suggesting that those parameters obtain the best signal. When looking at 
the 10% filter, it is evident that the best acquisition time is 5 seconds again as it produces a 
Run Time 
delay 
(minutes) 
Filter 
(%) 
Acquisition 
Time 
(seconds) 
Colloid 
dilution 
(%) 
Colloid 
peak 
height 
(n=3) 
Caffeine 
peak 
height 
(n=3) 
Caffeine: 
Colloid peak 
height ratio 
(n=3) 
1 30 1 1 100 0.025388 0.068715 2.71 
2 30 1 5 100 0.029638 0.083584 2.82 
3 30 1 10 100 0.031528 0.095726 3.04 
4 30 1 15 100 0.035727 0.113728 3.18 
5 30 1 20 100 0.030666 0.122867 4.01 
6 30 10 1 100 0.055814 0.08691 1.56 
7 30 10 5 100 0.033986 0.12761 3.76 
8 30 10 10 100 0.039213 0.130037 3.32 
9 30 25 1 100 0.036915 0.132188 3.58 
10 30 25 5 100 0.293000 1.150079 3.93 
high ratio. However when looking at the effect of the filter and the acquisition time as a 
whole, it is clear that the optimised parameters to use would be run 5 (highlighted in bold) 
as it produces the best signal with regards to the peak height ratio. This suggests that the 
filter is low enough so that the sample is not being saturated but there is a long enough 
acquisition time for the sample to generate enough energy to produce a good spectrum. 
The optimised Raman settings were then used for further studies.  
 
Table 12: Effect of changing the colloid dilution on the peak height ratio (normalised) 
 
Table 12 suggests that the best colloid to use is the 100%. This suggests that there is enough 
silver for the caffeine to bind to and in turn enables the signal to be enhanced. The other 
values suggest that by diluting the colloid with water essentially means that there is less 
silver colloid for the caffeine to bind to hence producing a weaker signal.  
 
4.6 Analysis of Theophylline in methanol using SERS 
The optimised method was used for the analysis of theophylline a metabolite of caffeine. 
Caffeine and theophylline have a very similar structure 
 
Figure 11: Caffeine and theophylline structures 
 
  
 
 
 
Caffeine      Theophylline  
Run Time laid 
(minutes) 
Filter 
(%) 
Acquisition 
Time 
(seconds) 
Colloid 
dilution 
(%) 
Colloid 
peak 
height 
(n=3) 
Caffeine 
peak 
height 
(n=3) 
Caffeine: 
Colloid peak 
height ratio 
(n=3) 
1 30 1 20 25 0.014724 0.018561 1.26 
2 30 1 20 50 0.493399 0.750212 1.52 
3 30 1 20 75 0.019741 0.050471 2.55 
4 30 1 20 100 0.017205 0.083953 4.88 
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 Figure 11 shows that caffeine has a CH3 attached to all three of the nitrogen groups whereas 
in theophylline one of the methyl groups has been replaced by a H. When analysing the 
caffeine and theophylline powder using conventional Raman their spectra are very similar.  
 
Figure 12: Comparison of Caffeine and Theophylline powder spectra using conventional 
Raman with 100% filter, 300 µm hole, acquisition time of 10 seconds and 2 scan cycles. 
Baseline corrected   
 
Looking at figure 12 it is evident that their spectra differ which is expected, there are shifts 
in the bands. Table 13 summarises the different bands for caffeine and theophylline. When 
comparing some of the peaks there are slight shifts between each spectrum. However there 
are two peaks that are found in the caffeine spectrum that cannot be seen in the 
theophylline spectra (738 cm-1 and 798 cm-1). This could be due to their difference in 
structure. Where caffeine has a N-CH3 functional group theophylline only has NH functional 
group, the difference in these group could be the cause of the slight difference in their 
spectra. The band at 798 cm-1 is assigned to N-C-H which corresponds with the conclusion 
that this band is not present in the theophylline spectrum because of the difference in 
structure. The main similarity in both spectra is the band at 1020 cm-1 this band has been 
enhanced in both caffeine and theophylline; suggesting that the part of the molecule that is 
closest to the silver nanoparticles is the pyridine ring which confirms Chen’s conclusion. 
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When comparing both their spectra using the correlation coefficient the value was 0.43 
which suggests that the spectra differ considerably.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assignment  Caffeine Theophylline 
N-C-C  441m 447m 
C-N-C  481ms 505ms 
O=C-N or pyridine 
ring  
553vs 557vs 
O=C-N  609vw 609vw 
O=C-N  641ms 667s 
C=O 696w 697w 
O=C-C 738s -  
N-C-H 798s -  
Imidazole ring  926s 928m 
Pyridine ring  973w 968m 
N-CH3 stretch  1020m  1049m 
In plane C-C 1067m 1071m 
C-N  1130vw -  
C=N stretch 1187vw 1190w 
C-N stretch  1238m 1214s 
C-N stretch 1283m  1290m 
Imidazole trigonal 
ring stretching  
1325vs 1319s 
C-N antisymmetric 
stretching  
1404w 1397w 
C=N stretch  1450vw -  
C-C stretch 1551vw 1566w 
C=C stretch  1600s 1608w 
C=O stretch 1657m 1665s 
C=O stretch  1698ms  1707m  
vw – very weak, w – weak, m – medium, ms – medium strong s –strong, vs – very strong 
 
When comparing the SERS spectra there are no significant differences, the only differences 
that can be seen is the intensity of the spectra (Figure 13). By comparing these spectra it 
also concludes that it is the C-N group that interacts the strongest with the silver colloid. The 
Table 13: Peaks of  
caffeine and  
theophylline with Raman 
spectroscopy   
 
difference between the two structures is bonds to hydrogen which explains why their 
spectra are very similar when analysing them using SERS. It would be expected to see a 
difference in their spectra when extending their range to 2500-3000 cm-1 as this is when the 
methyl groups are commonly found. One of the Raman bands that is present in caffeine is 
the band at 798 cm-1 which is assigned to N-C-H bond. However this band is not present in 
theophylline. This could be due to the hydrogen bonding between the CH3 that is present in 
caffeine but has been replaced in theophylline by a hydrogen.   
 
 
Figure 13: SERS spectrum of 25 µg/mL caffeine and theophylline with silver colloid and NaCl 
(0.1 M) Baseline corrected and normalised  
 
If the spectra are compared from 400-1800 cm-1 the correlation coefficient of caffeine and 
theophylline has a value of 0.99, showing that the spectra of caffeine and theophylline are 
almost identical. This is due to the position of the molecule on the silver colloid surface. As 
previously explained the N-CH3 group has the strongest interaction with the silver surface. 
This functional group is present in both caffeine and theophylline and therefore the SERS 
response is very similar between the two molecules as they are both behaving in the same 
way which explains why the spectra are similar.   
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4.7 Limit of detection (LOD) of caffeine in methanol using SERS  
The limit of detection is calculated as it allows the lowest quantity of a substance to be 
distinguished from the absence of that substance ie a blank. To do this a calibration graph 
needs to be produced. One method of calculating the limit of detection is by looking at the 
mean value of a blank and the standard deviation of a blank. Table 14 shows the methanol 
blanks and the different peak heights. 
 
Table 14: 10 replicates of MeOH blank and their peak heights at 1590 cm-1, 1619 cm-1 and 
1630 cm-1 
Replicates of 
MeOH blank 
Baseline peak 
(BPB) 
(1590 cm-1) 
 
Peak Height 
(1619 cm-1) 
Baseline peak 
(BPA) 
(1630 cm-1) 
PH – (BPB + BPA) 
    2 
1 5.50 8.33 8.15 1.51 
2 4.89 6.26 3.01 2.31 
3 8.11 15.98 10.31 6.77 
4 2.84 6.24 8.00 0.82 
5 3.02 6.06 8.38 0.36 
6 6.45 6.53 8.56 -0.98 
7 5.22 8.87 5.61 3.46 
8 2.20 6.44 6.38 2.15 
9 2.82 3.21 1.61 0.99 
10 2.04 5.86 4.42 2.63 
   Mean 2.00 
   SD 2.10 
 
The LOD can be deduced using this equation: 
- LOD = Mean blank + 3σblank  
- LOD = 2.00 + 3(2.10) 
- LOD = 22.97 Raman intensity units  
 
Once this has been established this would be substituted in as the y value and solve it for x 
which would then give the LOD in concentration. This would have been done however the 
calibration curve (figure 15) is not appropriate to use as it does not follow the linear trend 
expected (the response increases as the concentration increases) and the error bars overlap 
which means that being able to differentiate between the different concentrations is not 
possible. Therefore the conversion from intensity units to concentration would not be 
accurate. Another method for determining the LOD is the use of standards.  
 
Figure 14 shows the different concentrations of caffeine ranging from 10 ng/mL to 1 ng/mL. 
It is evident that as the concentration is decreasing so are the different bands. At 10 ng/mL 
there are some peaks that can be used to distinguish caffeine. However at 1 ng/mL the only 
peaks that are evident are the methanol peaks which can be found at 1000 cm-1 and 1450 
cm-1 
 
 
 
 
 
 
 
 
 
 
Figure 14: SERS spectra of caffeine at concentrations ranging from 10 ng/mL - 1 ng/mL 
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Table 15: The mean height of caffeine peak at 1619 cm-1 over a range of different 
concentrations 
Concentration 
(ng/mL) 
Mean  
(n=10) 
Standard Deviation 
10 30.79 12.33 
9 55.56 7.61 
8 45.37 13.99 
7 23.25 6.43 
6 15.63 1.39 
5 18.53 3.85 
4 14.41 0.97 
3 15.79 2.14 
2 16.70 1.75 
1 16.04 4.28 
 
If the sample is not above the blank + 3SD (22.97) then caffeine cannot be detected as it 
could be a blank measurement that is being seen. By looking at table 15, 10 ng/mL – 7 
ng/mL are all above the limit of detection value. 6 ng/mL – 1 ng/mL are not. Therefore the 
limit of detection for caffeine can be concluded as being between 10-7 ng/mL. This 
conclusion enables the optimisation of the settings attempting to obtain a spectrum of 
these samples that contains the bands of caffeine and thus determining the LOD of caffeine 
in methanol.  
 
Looking at table 16 it is clear that run 4 yields the highest caffeine to colloid peak ratio 
suggesting that it provides the best method that optimises the caffeine spectrum. This then 
enables the acquisition time to be looked at. To see if changing the amount of time the laser 
is exciting the sample has an effect on the spectrum produced. Table 17 shows the effect of 
changing the acquisition time for the analysis of caffeine. Run 1 evidently produces the best 
result as it yields the highest caffeine to colloid peak height ratio. These setting will now be 
used to determine the limit of detection for caffeine in methanol.  
 
 
 
Table 16: The effect on the peak height ratio when changing the filter percentage and the 
quantity of sample added using 10 ng/mL of caffeine solution 
Using the parameters that have been highlighted in bold (run 4), the acquisition time can 
now be optimised 
 
Table 17: The effect on the peak height ratio when changing the acquisition time 
 
Once these settings have been optimised, they can be applied to caffeine to determine the 
limit of detection. Figure 15 shows the calibration chart of different concentrations of 
caffeine. It is clear from this figure that the limit of detection of caffeine is 8 ng/mL however 
due to the error bars overlapping considerably differentiating between 8 ng/mL, 9 ng/mL 
and 10 ng/mL cannot be done as the quantification limit will be a lot higher than the limit of 
detection, it normally is the mean blank + 10σblank. 
Run Filter 
(%) 
 Quantity of 
sample 
(µl) 
Acquisition 
Time 
(seconds) 
Colloid peak 
height at 200 
cm1 (n=3) 
Caffeine 
peak height 
at 1619 cm-1 
(n=3) 
Caffeine: 
Colloid peak 
height ratio 
(n=3) 
1 25 100 30 44.35 67.54 1.52 
2 25 200 30 80.51 84.18 1.05 
3 25 300 30 52.04 84.58 1.63 
4 25 400 30 54.02 109.09 2.02 
5 50 100 30 53.03 38.43 0.72 
6 50 200 30 93.02 34.82 0.37 
7 50 300 30 86.39 36.49 0.42 
8 50 400 30 42.20 6.01 0.14 
9 100 100 30 50.01 39.73 0.79 
10 100 200 30 114.24 69.40 0.61 
11 100 300 30 262.69 171.34 0.65 
12 100 400 30 1696.90 392.46 0.23 
Run Filter 
(%) 
 Quantity of 
sample 
(µl) 
Acquisition 
Time 
(seconds) 
Colloid peak 
height 
(n=3) 
Caffeine 
peak 
height 
(n=3) 
Caffeine: 
Colloid peak 
height ratio 
(n=3) 
1 25 400 30 54.02 109.09 2.02 
2 25 400 40 145.80 178.55 1.22 
3 25 400 50 108.04 100.23 0.92 
Looking at both methods for determining the LOD, they give similar results. The calculated 
LOD using intensity units was said to be 22.97, which is supported by figure 15. The 
concentrations that are below 7 ng/mL also have a Raman intensity below 22.97.  
 
 
 
Figure 15: Calibration chart looking at different concentrations of caffeine in methanol. The 
black dot represents the peak height of the blank methanol (n=3, error bars are ±1SD) 
 
Higher concentrations of caffeine were looked at to see if it is possible to determine the 
quantity present. Looking at figure 16 it is clear that there is too much variation between 
the different concentrations. This could be due to a repeatability issue with the colloid and 
its batch-to-batch variability which could result in a different amount of silver chloride being 
added, different number of hot spots and different sizes of aggregates. One colloid can 
produce 10 samples that can be analysed. During this experiment a minimum of 3 batches 
was used. In future it would be ideal to make them individually, analyse them on the UV-Vis 
to determine their suitability and then pool them together to create a colloid that is stable. 
 Figure 16: Calibration chart looking at different concentrations of caffeine in water ranging 
from 20 ng/mL - 100 ng/mL. The black dot represents the peak height of the blank methanol 
(n=3, error bars are ±1SD) 
 
4.8 Optimising High-Performance Liquid Chromatography HPLC for the analysis of caffeine in 
methanol 
To optimise the HPLC method, caffeine and theophylline were analysed to determine if the 
different parameters provided good separation of the two molecules. The different 
parameters that were looked at were the retention time, peak height, peak area and peak 
shape. The retention time was looked at to see if it varied due to the different parameters. 
Peak area was analysed because it is consistent within the HPLC and relates to 
concentration. The peak height is measured to enable the peak shape to be calculated. The 
peak shape refers to the symmetry of the peaks on the chromatogram and whether there 
was any peak fronting or tailing. 
The flow rate was changed to see if there was a change in the retention time of the two 
substances and to see whether better separation could be achieved. Table 18 summarises 
the changes in parameters. 
Table 18: Different parameter changes and their effect on the retention time (RT), peak 
height, peak area and peak shape 
Change in Parameter RT  
(min) 
Peak height Peak Area Peak shape 
(area/height) 
Theophylline  Caffeine Theophylline  Caffeine  Theophylline  Caffeine  Theophylline  Caffeine  
Flow rate 
(mL/min) 
1.5 2.03 2.27 205544 1587663 9582950 12426232 46.62 7.83 
1.0 2.69 3.01 1447364 3027411 13114597 16441257 9.06 5.43 
0.5 5.31 5.95 1611438 3424491 24208632 31309265 15.02 9.14 
0.1 23.97 26.92 2417713 3293635 130974875 159049782 54.15 48.29 
Injection 
volume 
(µl) 
5 2.77 3.09 1360942 1423800 8637718 11784508 6.35 8.28 
10 2.69 3.01 1447364 3027411 13114597 16441257 9.06 5.43 
15 2.69 3.07 1813052 3857884 16250333 21812983 8.96 5.65 
20 2.69 3.07 2334641 4661989 20307367 28145480 8.70 6.04 
Concentration 
(Theo:Caff 
µg/mL) 
25:100 2.69 2.99 552564 2775530 2593307 16177745 29.28 5.83 
50:75 2.69 2.99 1089853 1906802 4892276 9308480 8.54 4.88 
75:50 2.69 2.99 1704555 1326938 8012427 7057271 4.14 5.32 
100:25 2.69 2.99 2293554 670880 11554061 4650312 2.03 6.93 
Mobile phase 
(MeOH:water 
%) 
100:0 2.69 3.01 1447364 3027411 13114597 16441257 9.06 5.4 
90:10 2.72 3.04 1748924 3056078 13071244 16295773 7.47 5.33 
80:20 3.33 3.71 1096044 1350760 6171842 7977296 5.63 5.91 
70:30 3.65 4.16 801191 751353 6462166 6894351 8.07 9.18 
 
 
 
 
 
 
 
 
 
 
 
 
The flow rate at 0.1 mL/min provides the best peak shape. The chromatogram also showed 
baseline separation and the peaks were sharp and clean. When comparing the different 
retention times, they have increased as the flow has decreased which is what was expected. 
It also shows that there is a longer separation between when theophylline and caffeine 
elute. Using these results, the 0.1 mL/min flow rate is the best flow rate to use when 
analysing these two substances. 
When analysing the different injection volumes, the 20 µl volume provided the best 
separation with the cleanest peaks. The other three injection volumes did not provide 
baseline separation and the peaks were not symmetrical. The results for the different 
volumes also show that the peak area increases with the amount that is injected again 
something that was expected.  
The concentrations were changed to see the effect on the peak area. Table 18 shows that 
when the concentration is increased of one of the substances the peak area increases. It 
also shows that changing the concentrations does not have an effect on the retention time. 
The reason concentrations were looked at is because when analysing a sample the 
concentrations are not necessarily going to be the same for the substances and its 
metabolites.   
The mobile phase was looked at as it can influence the spectrum which is shown in the 
table. When changing the mobile phase it changes the polarity so the substances should 
elute at different retention times which is visible in the results table. Another thing that 
changed was the baseline separation, there was complete separation with clean, sharp 
peaks with the 70:30 (MeOH:H2O) mobile phase as oppose to the 90:10.  
To summarise the best method to use for the analysis of caffeine is a flow rate of 0.1 
mL/min, a mobile phase of 70:30 and an injection volume of 20 µl as this gave the best 
separation of caffeine and theophylline.  
 
 
 
 
 
 
4.9 Limit of Detection of Caffeine using HPLC 
Using the optimised HPLC method the limit of detection of caffeine was determined. Figure 
17 shows chromatograms of different concentrations of caffeine. A peak at 2.7 minutes can 
be seen which is due to caffeine. As the concentration of caffeine decreases, the peak 
height of caffeine decreases. Looking at the chromatogram of caffeine at a concentration of 
0.1 µg/mL it is clear that the peak at 2.7 min is no longer distinguishable. This suggests that 
the limit of detection of caffeine using these HPLC settings is 0.2 µg/mL. 
 
 
Figure 17: Concentrations of caffeine in methanol ranging from 0.1 µg/mL - 1 µg/mL using 
the optimised HPLC settings. 
 
Figure 18 shows a calibration curve that was produced by plotting the peak area against 
known concentrations of caffeine. Table 18 shows the results used to produce the 
calibration curve. 
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Figure 18: Calibration curve showing different concentrations of caffeine in methanol (n=3, 
error bars are ±1SD and are within the size of the point) 
 
Table 19: Peak area of caffeine in methanol at different concentration with 3 replicates  
Concentration 
(µg/mL) 
Rep 1 Rep 2 Rep 3 Mean  Standard 
Deviation  
1 22248.98 22239.43 22203.45 22230.62 24.01 
0.8 18337.54 18324.15 18322.27 18327.99 8.33 
0.6 13596.75 13930.90 13813.79 13780.48 169.56 
0.4 8425.84 8460.65 8589.98 8492.16 86.49 
0.2 4894.23 4801.89 4799.12 4831.75 54.13 
 
Figure 19 shows a R2 value of 0.997 which shows that there is a linear relationship between 
the peak area and concentration. The R2 value depicts the quality of the gradient of the line. 
For quantitative techniques the desired R2 value is 0.98 or above. Other quantitative 
methods look at the use of an internal standard. An IS can be used to help build a 
calibration, by plotting the ratio of the signal from the analyte of choice to the signal from 
the IS which can aid the quantification. Factors that affect the signal of the analyte will 
affect the signal of the IS so the use of an IS can help correct for any loss of analyte during 
the sample preparation or sample injection. An IS normally has a similar chemical structure 
to the analyte. When analysing caffeine there are a number of different analytes that can be 
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used as an internal standard. A common IS used is theophylline due to it having a very 
similar structure to caffeine, however as theophylline is a metabolite of caffeine it could be 
present in the sample matrix. Therefore theophylline is not a suitable internal standard for 
the analysis of caffeine in saliva. Another analyte that has been used in the literature is 
benzotriazole, which was used for the analysis of caffeine and paraxanthine in saliva and 
plasma on a HPLC (Perera et al., 2010). When using this internal standard along with the 
optimised HPLC settings both caffeine and benzotriazole co-elute, therefore making it 
unsuitable to use for this analysis. Another IS that could be used is paracetamol.  
 
 
Figure 19: Chromatogram of paracetamol (A) and caffeine (B) 
 
Looking at figure 19 it is clear that both paracetamol and caffeine have complete baseline 
separation and different retention times. Therefore paracetamol can be used as a suitable 
internal standard, however in this case it is not. There is a possibility that paracetamol could 
be present in saliva, especially if the participant providing the sample has had paracetamol 
before the sample was taken. Another internal standard that could be used are the 
analogues of paracetamol; 2-acetamidophenol and 3-acetamidophenol. Figure 13 shows the 
chromatogram of caffeine and 3-acetamidophenol. By comparing the two different 
chromatograms there is not complete baseline separation, this could be improved by 
modifying the method (see section 6.1.1). However 3-acetamidophenol does have a similar 
0
5
10
15
20
25
30
0 0.5 1 1.5 2 2.5 3 3.5 4
A
b
so
rb
an
ce
 (
m
A
U
) 
Time (min) 
A 
B 
retention time to that of paracetamol again this would create a problem if the participant 
has taken paracetamol prior to providing a saliva sample.  
 
 
Figure 20: Chromatogram of 3-acetamidophenol (A) and caffeine (B) 
 
2-acetamidophenol was also considered as an internal standard (figure 21). Using the 
optimised method there is no baseline separation between 2-acetamidophenol and caffeine 
therefore making it unsuitable.  
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 Figure 21: Chromatogram of 2-acetamidophenol (A) and caffeine (B) 
 
The use of an internal standard for this piece of work would be unsuitable as the internal 
standards that have been investigated either co-elute or are not baseline separate. To 
improve the baseline separation modification of the existing HPLC method would need to be 
undertaken (section 6.1.1). When looking figure 18 it shows there is a good linearity 
between the peak area of caffeine and the concentration because of this the use of an 
internal standard wasn’t investigated further as the calibration curve is suitable for 
quantitative analysis.  
 
 
4.10 Liquid-Liquid Extraction (LLE) Technique  
A LLE technique for the determination of caffeine in non-alcoholic beverages was adapted 
for the analysis of caffeine in water (University of Lincoln, 2005). Caffeine in water was used 
as a means to test whether the extraction was suitable for the extraction of caffeine in 
saliva. To determine whether the extraction would be suitable a blank was analysed. As can 
be seen by Figure 22 there is some contamination (1-1.5 minutes) which is caused by the 
extraction technique. However there are no peaks at 2.5 minutes which is the time at which 
caffeine elutes. It can be concluded that the LLE is capable of analysing caffeine without any 
interfering peaks. 
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Figure 22: HPLC chromatogram of a blank sample (water) analysed after Liquid-Liquid 
Extraction  
Figure 23 shows the chromatogram of the LLE with a known concentration of caffeine. This 
demonstrates that the extraction technique is capable of extraction of caffeine in water. 
There are peaks present at 1 minute which can be concluded as something that has 
transferred over from the extraction technique. This can be deduced as the same peaks are 
present in the blank chromatogram (Figure 22) as well as the 1 µg/mL chromatogram below 
(Figure 23). 
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Figure 23: HPLC chromatogram of 1 µg/mL of caffeine in water analysed after Liquid-Liquid 
Extraction  
Different number of extractions was looked at to optimise the extraction technique. It can 
be concluded that two extractions is enough to fully extract the caffeine from the sample 
(Figure 24).  
 
 
Figure 24: HPLC chromatogram of different number of extractions using a 1 µg/mL sample of 
caffeine in water  
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As can be seen by figure 24 there are no peaks visible in the 3rd, 4th and 5th extraction apart 
from the methanol peak at 2 minutes, which would be expected, therefore concluding that 
2 extractions is enough to successfully extract caffeine. Once the extraction method has 
been optimised a calibration curve was produced for caffeine in water (Figure 25). 
 
 
Figure 25: Calibration curve of a liquid-liquid extraction of different concentrations of 
caffeine in water ranging from 0.6 - 2.5 µg/mL (n=3, error bars are ±1SD and are within the 
size of the point) 
 
4.11 Analysis of Caffeine in Saliva 
To be able to quantify caffeine in saliva a calibration curve needs to be produced that can be 
used to help quantify participants’ saliva samples. Caffeine free saliva was collected from 
myself throughout the experiment. No caffeine was consumed for over 24 hours before the 
saliva sample was taken and so this was assumed to be caffeine-free. Figure 26 shows the 
calibration curve of caffeine in saliva.  
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 Figure 26: Calibration curve of a liquid-liquid extraction of different concentrations of 
caffeine in saliva ranging from 0.6 - 2.5 µg/mL (n=3, error bars are ±1SD) 
 
Validation was under taken to determine the precision and the accuracy of the calibration 
curve that will be used for the quantification of caffeine. Three independent samples (top, 
middle and bottom) at known concentrations were prepared and analysed on the HPLC. 
They were injected in duplicate and an average was taken which was then used to predict 
the amount of caffeine present. 
 Table 20: Calculations for the validation set ranging over 2 days 
Sample of known 
concentration (µg/mL) 
 
 Day 1 Day 2 
Average peak 
area 
Standard 
Deviation 
Concentration 
(µg/mL) 
Average peak 
area 
Concentration 
(µg/mL) 
1.0 12553.91 315.10 1.02 - - 
1.7 24430.32 464.70 1.78 - - 
2.5 35015.28 120.14 2.46 - - 
  
Table 20 demonstrates that day one of the validation there is a slight bias towards a high 
results. When the samples were analysed on day two, there was no caffeine present in any 
of the vials suggesting that there could have been an instrument failure ie miss-injection. It 
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is unlikely that caffeine degraded over night because Perera et al (2010) concluded that 
caffeine was stable refrigerated at 4⁰C and room temperature for 14 days. This put an end 
to the validation set. Ideally the validation should be done over a number of days 
demonstrating the precision of the calibration and the accuracy.  
To determine if the two different matrices are comparable the calibration graph of caffeine 
in water was plotted against the calibration graph of caffeine in saliva (Figure 27). 
 
 
Figure 27: Calibration curve comparing the peak areas of caffeine in water against the peak 
areas of caffeine in saliva (n=3, error bars are ±1SD and are within the size of the point) 
 
The R2 value is 0.9963 which shows that for the same concentration the signal increases in 
the same way for both techniques. If there was a gradient of 1 it would show that the two 
techniques are the same, the same response is obtained from saliva and water. However 
the signal is much more reduced in saliva suggesting that there is a matrix effect. This 
suggests that the caffeine is not as easily extracted from saliva as it is in water which could 
be down to a number of reasons, for example the proteins that are found in saliva could be 
having an effect on the caffeine extraction. The equation of the line seen in Figure 26 was 
the equation used to quantify the caffeine in saliva.  
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LLE of caffeine in water  
4.12 Analysing Saliva samples from participants  
A consent form was given to the participants explaining what the experiment included and 
assured them that no medical information would be gathered from this experiment. Each 
participant was given a unique code to keep their identity anonymous (see section 8). 
Before analysing the saliva samples from the participants, they were asked to go 24 hours 
without any form of caffeine to ensure that the result that is gathered is down to the 
caffeine that was consumed when the saliva was given. To ensure that each participant had 
no caffeine in their system before the start of the experiment a saliva sample (blank) was 
taken, they then consumed a normal cup of coffee and after half an hour their saliva was 
collected in the salivettes. An average cup of coffee contains approximately 85 mg of 
caffeine (McCusker et al., 2003). It was then extracted, blown down to dryness and 
reconstituted in methanol. The sample was then analysed by SERS and by HPLC. However 
when the samples were analysed there was no caffeine response. Ideally the saliva could 
have been analysed directly to the colloid. The direct analysis of caffeine in saliva was not 
looked at because when trying to analyse caffeine in water it was unsuccessful so the 
assumption was that direct analysis would not be successful as saliva is 99% water. This is 
explained further in the further research section (section 6). The optimised HPLC method 
was used to quantify the caffeine content. Figure 28 and 29 shows an example of one of the 
participant’s blank saliva sample and their saliva sample after the consumption of caffeine.  
 
 
 
 Figure 28: Participant A3B8’s blank saliva sample 
 
 
Figure 29: Participant A3B8’s saliva sample after the consumption of caffeine 
 
Comparing both figure 28 and 29 it is clear that there was no caffeine present in the blank 
saliva sample and that the presence of caffeine in figure 29 is down to the caffeine 
consumed that day and not from prior caffeine consumption. All of the samples were 
analysed on the HPLC in duplicate then an average was taken. The equation that is in figure 
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26 was rearranged in order to calculate the concentrations of the caffeine for each 
individual. There is an example of the equation being used in appendix 2 (see section 8).  
 
Table 21: Calculation for the concentration of caffeine in saliva for 8 different participants 
(n=2) 
Participant Average peak area Calculated concentration 
(µg/mL) 
A3B8 24033.160 1.76 
A5B5 26705.735 1.92 
A6B3 24894.340 1.81 
A9B2 21128.365 1.57 
A1B1 26850.560 1.94 
A5B3 20115.897 1.51 
A2B9 23094.074 1.70 
A7B1 25956.524 1.88 
 
It can be concluded that the analytical HPLC method is capable of determining 
concentrations of caffeine in different individual’s saliva. Chloroform is not a good 
extracting solvent for proteins and they are unlikely to be present in the caffeine extracts. It 
is more likely to be other chloroform soluble substances that are extracted that may be 
interfering with the SERS analysis. This can be confirmed when looking at figure 29; there 
are some interfering peaks that can be seen in the chromatogram which could be stopping 
the caffeine from binding to the hotspots. Table 21 shows that the range of caffeine in saliva 
is between 1.51-1.94 µg/mL, the limit of detection for the optimised SERS method was 
significantly lower than the concentrations that were found in saliva. This suggests that the 
quantification using SERS could be possible if the calibration standards were at a 
concentration that reflects the amount of caffeine found in saliva. 
 
 
 
 
 
5. Conclusions 
 
It can be concluded that this research has efficiently been able to confirm the presence of 
caffeine in low quantities. This highlights that Surface Enhanced Raman Spectroscopy is a 
more sensitive technique for looking at lower limits of detection of specific analytes 
compared to Raman spectroscopy. The original aim of this research was to develop a SERS 
method capable of quantifying caffeine in saliva. However this proved problematic for a 
number of reasons discussed in the further research section. SERS was then going to be 
used as a confirmation technique. However using SERS as a technique to confirm the 
presence of caffeine in saliva samples was unsuccessful. More investigations into the 
reasons why SERS did not work would need to be studied. This research was also able to 
produce a HPLC method for the analysis of caffeine in saliva and quantify that amount of 
caffeine in different individual’s saliva.   
6. Further research 
 
6.1 The use of an Internal Standard 
6.1.1 HPLC method optimisation 
The HPLC method has proven its capability of being able to quantify caffeine in saliva. One 
thing that could have been done to improve the HPLC method is the use of an internal 
standard (IS). A number of different internal standards were looked at to use with this 
study, however they either co-eluted with caffeine or eluted too close together that there 
was no base line separation. There are a number of ways to improve this, an IS that would 
not co-elute would be the best however it would need to be a standard that does not 
naturally occur in the body and is not a bi-product of caffeine. Using theophylline would not 
be suitable as it is a bi-product of caffeine along with theobromine. Paracetamol however 
did provide baseline separation (see section 4.9) but as explained previously if any of the 
participants have taken paracetamol prior to the investigation it would affect the result 
obtained. One other way to improve the method would be to optimise the method so that 
baseline separation could be obtained between either 2-acetamidophenol or 3-
acetamidophenol and caffeine. This could be done by looking at the flow rate and modifying 
it accordingly until baseline separation is obtained.  
 
6.1.2 Liquid-liquid extraction  
By using an internal standard this could have been added to the saliva sample before the 
caffeine had been extracted, by doing this it not only would have aided the quantification as 
a peak area ratio would have been taken rather than relying just on the peak area of 
caffeine it would have also meant that the percentage recovery could be monitored in the 
extraction. If a known concentration of internal standard is added and the same amount is 
extracted and quantified than it can be certain that 100% of the IS is being recovered and 
therefore 100% of the caffeine is also being recovered.    
 
 
 
 
 
6.2 SERS method 
6.2.1 Optimisation of the colloid  
One of the problems that was observed during this research was the repeatability of the 
colloid. As Peter White explained there is a problem with producing colloid solutions that 
have a good batch-to-batch reproducibility and stability. This was observed when preparing 
the colloid solutions, if the steps were not followed in the precise way and they were not 
done accurately than the colloid does crash. It takes a great level of skill in order to be able 
to produce repeatable colloids, if the hydroxylamine phosphate was not added straight and 
in the middle of the vial the colloids had a tendency to come out of solution. One way to 
improve the repeatability of the colloid would be to pool all of the individual vials together 
that way the individual colloid solutions would be mixed together and made uniform.  
 
6.2.2 Optimisation of caffeine in water  
To improve the method used saliva could have been added directly to the colloid rather 
than having to use an extraction technique and reconstitute in methanol. However during 
this research when caffeine was analysed in water with SERS a spectrum was not obtained. 
An assumption was made that if caffeine in water would not work then caffeine saliva would 
not work either. In order to improve the SERS method it needs to be optimised with regards 
to caffeine in water. As the majority of saliva is water, water could have been used to 
optimise a method. The aggregation needs to be considered as it plays a key part in the 
enhancement; if caffeine was not “sticking” to the SERS hotspots then a spectrum would 
have not been obtained.  
 
6.3 HPLC method  
When trying to validate the HPLC method on day 1 the results obtained were close to the 
actual amount that was injected. However on day two there were no peaks present from 
the caffeine samples. One improvement would be to determine the shelf life of caffeine and 
determine what temperature is best to store caffeine.  
 
6.4 Quantitative method using SERS 
A common method that is being looked at to quantify concentrations using spectroscopy is 
multi-variant analysis (Khoshayand et al., 2008). One of the most frequent used methods for 
multi-variant analysis is partial least squares regression (PLS) which is based on latent 
variable decomposition. There are two different procedures to use; PLS1 and PLS2. PLS1 is 
one model that is built for each analyte and PLS2 is a calibration model that is constructed 
of all the analytes of interest (Khoshayand et al., 2008). In order to build a model reference 
data would need to be collected. In this case, a set of caffeine standards would be selected 
and scanned using SERS then analysed on the HPLC to obtain the ‘actual’ concentration 
value. This would be done for both the standards and samples. Using the correct software 
the scanned samples would be plotted against the actual concentration obtained by the 
HPLC. This would then be the calibration model which can be optimised by looking at the 
use of different regions for example the spectral regions that are associated with caffeine 
would be selected, different principal components and different smoothing tools. Once the 
model is built and validated, it can be used to predict the concentration of unknown 
samples. 
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8. Appendices 
 
Appendix 1: Example of the consent form each participant filled out  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2: Equation used to calculate the caffeine present in saliva 
 
Equation of the line: 
 y = 15685x - 3533 
Rearranged to: 
 y = (x + 3533) 
     15685 
 
Example  Conc = (24033.16 + 3533)    = 1.76 µg/mL 
  
                         15685 
 
 
